# Xieteng

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/xieteng

- Industry: Software
- Headquarters: Hangzhou, China
- Website: www.xietengkeji.com
- Latest round: Angel (Dec 7, 2023)
- Investors on record: 1

## About

Founded in 2016 and based in Hangzhou, China, Xieteng is a medical technology company that provides integrated thrombosis prevention and treatment solutions. In 2018, the company participated in the construction of VTE safety and quality control standards for the Department of Critical Care Medicine in Zhejiang Province. In 2019, it launched VTE thrombosis prevention and management software. In December 2023, the firm closed an angel funding.

The company's main products include VTE management systems, VTE thrombosis prevention and treatment management software and medical intermittent inflatable anti-thrombotic systems. The VTE management system provides services such as high-risk screening warnings, preventive medical advice and recommendations, and monitoring of patient prevention status. The company's products are used in hospitals and other fields.

## Funding rounds

- Angel, Dec 7, 2023 — Tunlan Investment

## Investors

- Tunlan Investment (https://capitalatlas.ai/funds/tunlan-investment) — Angel